BAUM CHARLES M bought ACRV
June 17, 2026 · Form 4 insider transaction
BAUM CHARLES M bought 20,275 shares of Acrivon Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,275
Price
$0.00
Total value
N/A
InsiderBAUM CHARLES M
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 17, 2026
Filing dateJune 22, 2026
Shares owned after20,275
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through the applicable vesting date.